Category: encephalitis
A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Instit
Boston, Mass. -- MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
The radio show I discussed a couple weeks ago finally aired.
At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson's disease and possibly other neurological problems later in life, according to new research from St. Jude Children's Research Hospital.
Eczema patients at risk for serious viral infections have more severe disease, are more likely to be allergic to food and other allergens, and have a frequent history of staph infections, according to researchers at National Jewish Health and other institutions in the NIH-funded Atopic Dermatitis Vaccinia Network.
A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI), along with the Harvard School of Dental Medicine.
NEW YORK (March 5, 2009) -- Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology.
Virginia Tech entomologists have documented for the first time the presence of mosquitoes infected with La Crosse virus in four Southwest Virginia Counties. Sally Paulson, an associate professor of entomology, said the find from samples taken last year and recently analyzed was surprising because no human cases of the disease had been reported in the counties before. "It surprised me to get so many positives from so few samples from a place I wouldn't have expected any," Paulson said.
A seemingly mild "insult" to the brain could sensitize neurons to attack by immune system proteins that are otherwise protective, researchers have found. The finding could explain why sufferers of Alzheimer's and other neurodegenerative diseases significantly worsen following such insults. The scientists believe that drugs to selectively inhibit the immune proteins could reduce the rate of neural damage in a wide range of neurodegenerative diseases. Such drugs could also protect other organs against damage from autoimmune diseases such as lupus and rheumatoid arthritis, in which the immune system attacks body tissues.
In response to outbreaks of West Nile virus throughout the eastern U.S., the Centers for Disease Control and Prevention has pointed out that the best way to avoid infection is to avoid mosquito bites. West Nile virus is spread by the bite of an infected mosquito, and in addition to humans can infect horses, many species of birds, and some other animals. Fortunately, most people who become infected with West Nile virus will have either no symptoms or mild ones. But on rare occasions, infection can result in West Nile encephalitis, a severe and sometimes fatal inflammation of the brain. (The risk of severe infection is higher for persons 50 years of age and older.) Officials in Washington D.C. have been getting the word out about protective measures people can take after West Nile virus infected a 55-year-old resident, who is now hospitalized with encephalitis. As of Thursday, state health departments around the U.S. have released information on 113 cases of human illness related to West Nile virus this year, including 5 deaths.
